Moderna

Activity by year

2020202120222023202420252026

PartnershipContract

Mar 8, 2021CONTRACTBloomington, Indiana, United States
Baxter BioPharma Solutions to manufacture Moderna COVID-19 vaccine doses
Baxter BioPharma Solutions and Moderna have entered an agreement for Baxter to provide fill/finish sterile manufacturing services for approximately 60-90 million doses of the Moderna COVID-19 vaccine in 2021 at its Bloomington, Indiana facility.
Baxter International Moderna customer businesswire.com biospace.com
May 5, 2020PARTNERSHIP
Moderna and Lonza collaborate to manufacture COVID-19 vaccine
Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna's mRNA vaccine (mRNA-1273) against the novel coronavirus and additional Moderna products in the future.
Lonza Group AG partner Moderna partner #Specialty Chemicals socma.org

Suppliers

Partners

Loading…